Diabetes, Vol 48, Issue 4 848-854, Copyright © 1999 by American Diabetes Association

ARTICLES

Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes

AH Xiang, RK Peters, E Trigo, SL Kjos, WP Lee and TA Buchanan
Department of Preventive Medicine, University of Southern California School of Medicine, Los Angeles, USA.

Detailed metabolic studies were carried out to compare major regulatory steps in glucose metabolism in vivo between 25 normal pregnant Latino women without and 150 pregnant Latino women with gestational diabetes mellitus (GDM). The two groups were frequency-matched for age, BMI, and gestational age at testing in the third trimester. After an overnight fast, women with GDM had higher fasting plasma glucose (P = 0.0001) and immunoreactive insulin (P = 0.0003) concentrations and higher glucose production rates (P = 0.01) but lower glucose clearance rates (P = 0.001) compared with normal pregnant women. During steady-state hyperinsulinemia (approximately 600 pmol/l) and euglycemia (approximately 4.9 mmol/l), women with GDM had lower glucose clearance rates (P = 0.0001) but higher glucose production rates (P = 0.0001) and plasma free fatty acid (FFA) concentrations (P = 0.0002) than the normal women. These intergroup differences persisted when a subgroup of 116 women with GDM who were not diabetic < or = 6 months after pregnancy were used in the analysis. When all subjects were considered, there was a very close correlation between glucose production rates and plasma FFA concentrations throughout the glucose clamps in control (r = 0.996) and GDM (r = 0.995) groups. Slopes and intercepts of the relationships were nearly identical, suggesting that blunted suppression of FFA concentrations contributed to blunted suppression of glucose production in the GDM group. In addition to these defects in insulin action, women with GDM had a 67% impairment of pancreatic beta-cell compensation for insulin resistance compared with normal pregnant women. These results demonstrate that women with GDM have multiple defects in insulin action together with impaired compensation for insulin resistance. Our findings suggest that defects in the regulation of glucose clearance, glucose production, and plasma FFA concentrations, together with defects in pancreatic beta-cell function, precede the development of type 2 diabetes in these high-risk women.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. I. Goran, C. Lane, C. Toledo-Corral, and M. J. Weigensberg Persistence of Pre-Diabetes in Overweight and Obese Hispanic Children: Association With Progressive Insulin Resistance, Poor {beta}-Cell Function, and Increasing Visceral Fat Diabetes, November 1, 2008; 57(11): 3007 - 3012. [Abstract] [Full Text] [PDF]

				T. A. Buchanan, A. Xiang, S. L. Kjos, and R. Watanabe What Is Gestational Diabetes? Diabetes Care, July 1, 2007; 30(Supplement_2): S105 - S111. [Full Text] [PDF]

				R. M. Watanabe, M. H. Black, A. H. Xiang, H. Allayee, J. M. Lawrence, and T. A. Buchanan Genetics of Gestational Diabetes Mellitus and Type 2 Diabetes Diabetes Care, July 1, 2007; 30(Supplement_2): S134 - S140. [Full Text] [PDF]

				R. N. Bergman Orchestration of Glucose Homeostasis: From a Small Acorn to the California Oak Diabetes, June 1, 2007; 56(6): 1489 - 1501. [Full Text] [PDF]

				R. M. Watanabe, H. Allayee, A. H. Xiang, E. Trigo, J. Hartiala, J. M. Lawrence, and T. A. Buchanan Transcription Factor 7-Like 2 (TCF7L2) Is Associated With Gestational Diabetes Mellitus and Interacts With Adiposity to Alter Insulin Secretion in Mexican Americans Diabetes, May 1, 2007; 56(5): 1481 - 1485. [Abstract] [Full Text] [PDF]

				S. Lambin, R. van Bree,, I. Vergote, and J. Verhaeghe Chronic Tumor Necrosis Factor-{alpha} Infusion in Gravid C57BL6/J Mice Accelerates Adipose Tissue Development in Female Offspring Reproductive Sciences, December 1, 2006; 13(8): 558 - 565. [Abstract] [PDF]

				C. Zhang, S. Liu, C. G. Solomon, and F. B. Hu Dietary Fiber Intake, Dietary Glycemic Load, and the Risk for Gestational Diabetes Mellitus Diabetes Care, October 1, 2006; 29(10): 2223 - 2230. [Abstract] [Full Text] [PDF]

				A. H. Xiang, C. Wang, R. K. Peters, E. Trigo, S. L. Kjos, and T. A. Buchanan Coordinate Changes in Plasma Glucose and Pancreatic {beta}-Cell Function in Latino Women at High Risk for Type 2 Diabetes. Diabetes, April 1, 2006; 55(4): 1074 - 1079. [Abstract] [Full Text] [PDF]

				M. N. Montoro, S. L. Kjos, M. Chandler, R. K. Peters, A. H. Xiang, and T. A. Buchanan Insulin Resistance and Preeclampsia in Gestational Diabetes Mellitus Diabetes Care, August 1, 2005; 28(8): 1995 - 2000. [Abstract] [Full Text] [PDF]

				T. L. Setji, A. J. Brown, and M. N. Feinglos Gestational Diabetes Mellitus Clin. Diabetes, January 1, 2005; 23(1): 17 - 24. [Abstract] [Full Text] [PDF]

				A. H. Xiang, R. K. Peters, S. L. Kjos, J. Goico, C. Ochoa, A. Marroquin, S. Tan, H. N. Hodis, S. P. Azen, and T. A. Buchanan Pharmacological Treatment of Insulin Resistance at Two Different Stages in the Evolution of Type 2 Diabetes: Impact on Glucose Tolerance and {beta}-Cell Function J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2846 - 2851. [Abstract] [Full Text] [PDF]

				C.J. Glueck, N. Goldenberg, P. Wang, M. Loftspring, and A. Sherman Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy Hum. Reprod., March 1, 2004; 19(3): 510 - 521. [Abstract] [Full Text] [PDF]

				C. S. Yajnik, C. V. Joglekar, A. N. Pandit, A. R. Bavdekar, S. A. Bapat, S. A. Bhave, S. D. Leary, and C. H.D. Fall Higher Offspring Birth Weight Predicts the Metabolic Syndrome in Mothers but Not Fathers 8 Years After Delivery: The Pune Children's Study Diabetes, August 1, 2003; 52(8): 2090 - 2096. [Abstract] [Full Text] [PDF]

				P. M. Catalano, J. P. Kirwan, S. Haugel-de Mouzon, and J. King Gestational Diabetes and Insulin Resistance: Role in Short- and Long-Term Implications for Mother and Fetus J. Nutr., May 1, 2003; 133(5): 1674S - 1683. [Abstract] [Full Text] [PDF]

				T. A. Buchanan, A. H. Xiang, R. K. Peters, S. L. Kjos, A. Marroquin, J. Goico, C. Ochoa, S. Tan, K. Berkowitz, H. N. Hodis, et al. Preservation of Pancreatic {beta}-Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic Women Diabetes, September 1, 2002; 51(9): 2796 - 2803. [Abstract] [Full Text] [PDF]

				P. Catalano The Diabetogenic State of Maternal Metabolism in Pregnancy NeoReviews, September 1, 2002; 3(9): e165 - 172. [Full Text] [PDF]

				R. N. Bergman, M. Ader, K. Huecking, and G. Van Citters Accurate Assessment of {beta}-Cell Function: The Hyperbolic Correction Diabetes, February 1, 2002; 51(90001): S212 - 220. [Abstract] [Full Text] [PDF]

				L. Jovanovic and D. J. Pettitt Gestational Diabetes Mellitus JAMA, November 28, 2001; 286(20): 2516 - 2518. [Full Text] [PDF]

				T. A. Buchanan Pancreatic B-Cell Defects in Gestational Diabetes: Implications for the Pathogenesis and Prevention of Type 2 Diabetes J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 989 - 993. [Full Text]

				C. Homko, E. Sivan, X. Chen, E. A. Reece, and G. Boden Insulin Secretion during and after Pregnancy in Patients with Gestational Diabetes Mellitus J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 568 - 573. [Abstract] [Full Text]

				S. L. Kjos and T. A. Buchanan Gestational Diabetes Mellitus N. Engl. J. Med., December 2, 1999; 341(23): 1749 - 1756. [Full Text] [PDF]

				P. M. Catalano, S. E. Nizielski, J. Shao, L. Preston, L. Qiao, and J. E. Friedman Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E522 - E533. [Abstract] [Full Text] [PDF]